APA (7th ed.) Citation

Dupont, M., Carlier, C., Gower-Rousseau, C., Barbier-Lider, P., Botsen, D., Brasseur, M., . . . Bouché, O. (2022). Incidence and associated factors of cetuximab-induced hypersensitivity infusion reactions in 1392 cancer patients treated in four French areas: A possible association with Lyme disease? BMC Cancer, 22(1), 1. https://doi.org/10.1186/s12885-022-10192-4

Chicago Style (17th ed.) Citation

Dupont, M., et al. "Incidence and Associated Factors of Cetuximab-induced Hypersensitivity Infusion Reactions in 1392 Cancer Patients Treated in Four French Areas: A Possible Association with Lyme Disease?" BMC Cancer 22, no. 1 (2022): 1. https://doi.org/10.1186/s12885-022-10192-4.

MLA (9th ed.) Citation

Dupont, M., et al. "Incidence and Associated Factors of Cetuximab-induced Hypersensitivity Infusion Reactions in 1392 Cancer Patients Treated in Four French Areas: A Possible Association with Lyme Disease?" BMC Cancer, vol. 22, no. 1, 2022, p. 1, https://doi.org/10.1186/s12885-022-10192-4.